Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin

Lupin

BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:50
1052.50
3.6 (0.34%)
VOLUME 10,865
LIVE
NSE
Oct 19, 19:49
1051.20
2 (0.19%)
VOLUME 94,104
News on Lupin
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Samvat 2074: Jhunjhunwala says mkt staring at 'very long' bull run; bets on complex generics in pharma 

9.13 am | 17 Oct 2017 |  Source: CNBC-TV18

Jhunjhunwala is also optimistic on the story of financial savings and feels that large part of savings being invested into equity has just started....

Lupin readies for a mega specialty drug play with $1-bn war chest

7.43 am | 13 Oct 2017 |  Source: Moneycontrol.com

Lupin on Wednesday has agreed to buy US-based Symbiomix Therapeutics for USD 150 million. The drug maker will be doing several deals in the coming qua...

Lupin gains 2% on Symbiomix acquisition; brokerages hail move

2.37 pm | 12 Oct 2017 |  Source: Moneycontrol.com

Believe that the buyout could enrich its pipeline and there could be some recovery going forward for the company....

Expect acquisitions to boost growth; several products lined up for next year: Lupin 

11.11 am | 12 Oct 2017 |  Source: CNBC-TV18

Lupin acquired American firm Symbiomix Therapeutics for USD 150 million. The company says they expect significant cash flows from the deal in the next...

Lupin's board meeting on October 30, 2017

9.47 am | 12 Oct 2017 |  Source: Moneycontrol.com

Meeting of the Board of Directors of the Company will be held on Monday, October 30, 2017 at Mumbai, inter alia to consider and take on record unaudit...

Lupin's US arm takes over Symbiomix Therapeutics

11.55 am | 11 Oct 2017 |  Source: PTI

Lupin had entered into an arrangement to acquire the company earlier this year. The acquisition has been made for a cash consideration of USD 150 mill...

Lupin launches pain relieving tablets in US

6.23 pm | 10 Oct 2017 |  Source: PTI

Drug firm Lupin today said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market....

Lupin launches generic Norco tablets in US

3.16 pm | 10 Oct 2017 |  Source: Moneycontrol.com

Lupin has launched Hydrocodone Bitartrate and Acetaminophen tablets USP, 5mg/325 mg, 7.5 mg / 325 mg and 10 mg / 325 mg having received an approval fr...

Lupin gains 3% on USFDA approval for hypertension drug

3.11 pm | 10 Oct 2017

The Nadolol tablets is a generic version of US WorldMeds, LLC Corgard Tablets, 20 mg, 40 mg and 80 mg....

Stocks in the news: Lupin, Va Tech Wabag, Ujjivan, Mercator, Piramal Enterprises 

8.15 am | 10 Oct 2017 |  Source: CNBC-TV18

Lupin | Va Tech Wabag | Ujjivan Financial Services | Mercator | Piramal Enterprises | ONGC | L&T | M&M and Sharon Bio Medicine are stocks, which are i...

PM economic advisory panel to hold first meet tomorrow

7.17 am | 10 Oct 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Lupin gets USFDA nod for generic anti-hypertension Nadolol pills

6.03 pm | 09 Oct 2017 |  Source: Moneycontrol.com

Nadolol tables had annual sales of around USD 109.8 million in US in the year ended June 2017....

Lupin gets USFDA nod for infection treating drug

4.06 pm | 29 Sep 2017 |  Source: PTI

The company has received USFDA'S final approval for its doxycycline hyclate tablets in the strengths of 75 mg and 150 mg, Lupin said in a BSE fili...

Fund houses still cautious on pharmaceutical sector: HDFC Securities 

3.37 pm | 27 Sep 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Amey Chalke, Research Analyst of HDFC Securities spoke about the latest happenings in pharma sector and shared his views...

Lupin gets USFDA nod for generic version of Clobex lotion

3.22 pm | 25 Sep 2017 |  Source: PTI

The Mumbai-based firm said in a statement that it has received final approval for its product from the US Food and Drug Administration (USFDA)....

Buy Lupin; target of Rs 1125: Motilal Oswal

11.42 am | 22 Sep 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1125 in its research report dated September 13, 20...

Buy Lupin, NBCC, Dewan Housing Finance: Ashwani Gujral 

1.55 pm | 21 Sep 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com suggests buying Lupin, NBCC and Dewan Housing Finance....

Remain invested in Lupin: Prakash Gaba 

3.26 pm | 18 Sep 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that one may remain invested in Lupin....

Buy Lupin on dips, says Prakash Gaba 

3.55 pm | 15 Sep 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com advises buying Lupin on dips....

Buy Lupin, Bajaj Auto: Mitessh Thakkar 

3.36 pm | 15 Sep 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com recommends buying Lupin and Bajaj Auto....

1 2 3 4 5
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.